Additionally, miR-30e and miR-181a have been shown to enhance the sensitivity of GC cells to chemotherapeutic agents by inhibiting chemo-induced autophagy via targeting ATG5 (91, 158). This evidence concerns the gene ATG5 and gastric cancer.